What is MDCS Dermatology?
Founded in 2010 by Dr. Snehal Amin and Dr. Noah Gratch, MDCS Dermatology has evolved into a multi-location powerhouse specializing in comprehensive skin health. The practice bridges the gap between essential medical dermatology—including complex skin cancer surgery—and high-end cosmetic procedures. By maintaining a dual focus on clinical rigor and patient-centric care, the organization has established a significant market presence. Their operational model leverages a sophisticated approach to dermatological medicine, ensuring that both reconstructive surgical needs and aesthetic desires are met with professional precision. This commitment to excellence has resulted in a strong reputation and a loyal patient base, positioning the firm as a leader in the regional healthcare landscape.
How much funding has MDCS Dermatology raised?
MDCS Dermatology has raised a total of $467K across 2 funding rounds:
Debt
$150K
Debt
$317K
Debt (2020): $150K with participation from PPP
Debt (2021): $317K led by PPP
Key Investors in MDCS Dermatology
PPP
Public-Private Partnership
What's next for MDCS Dermatology?
With the successful acquisition of $317K, MDCS Dermatology is well-positioned to accelerate its strategic expansion. The firm is expected to utilize this capital to enhance its clinical infrastructure, potentially increasing its geographic reach within the tri-state area. As the practice moves into this next phase of development, the focus will likely shift toward integrating advanced surgical technologies and optimizing patient throughput without compromising the high standards of care that define the brand. By leveraging this financial backing, the leadership team aims to solidify its dominance in the dermatology sector, ensuring long-term sustainability and continued excellence in both medical and cosmetic service delivery.
See full MDCS Dermatology company page
